MYLS22

CAS No. 306959-01-3

MYLS22( —— )

Catalog No. M23118 CAS No. 306959-01-3

MYLS22 is a first-in-class and selective optic atrophy 1 (OPA1) inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 60 In Stock
2MG 33 In Stock
5MG 54 In Stock
10MG 92 In Stock
25MG 158 In Stock
50MG 235 In Stock
100MG 364 In Stock
200MG 546 In Stock
500MG 864 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    MYLS22
  • Note
    Research use only, not for human use.
  • Brief Description
    MYLS22 is a first-in-class and selective optic atrophy 1 (OPA1) inhibitor.
  • Description
    MYLS22 is a first-in-class and selective optic atrophy 1 (OPA1) inhibitor. MYLS22 can target endothelial OPA1 to curtail tumor growth and inhibits angiogenesis by impinging on NFkB activity and on angiogenic gene expression.
  • In Vitro
    Western Blot Analysis Cell Line:MLE12 cells Concentration:10 nM Incubation Time:30 min Result:Increased the phosphorylation levels of RIPK3 and MLKL protein.
  • In Vivo
    Animal Model:LPS‐induced ALI miceDosage:12.5 mg/kg Administration:i.p., 2 days Result:Increased lung inflammatory score, Tnf‐α and pro‐Il‐1β mRNA expression, and total IL‐1β or IL‐1β p17 protein expression.Increased the levels of RIPK3, MLKL protein, and their phosphorylation.Decreased the levels of SPC protein.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    OPA1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    306959-01-3
  • Formula Weight
    443.52
  • Molecular Formula
    C??H??N?O?S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 50 mg/mL (112.73 mM; ultrasonic and warming and heat to 60°C)
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Stéphanie Herkenne, et al. Developmental and Tumor Angiogenesis Requires the Mitochondria-Shaping Protein Opa1. Cell Metab. 2020 May 5;31(5):987-1003.e8.
molnova catalog
related products
  • Hypercalcemia Malign...

    pTH-Related Protein (1-34) amide (human, mouse, rat) (Human PTHrP-(1-34)NH2) is a N-terminal fragments of PTHrP. pTH-Related Protein (1-34) amide (human, mouse, rat) induces hypercalcemia, and can be used for research of humoral hypercalcaemia of malignancy.

  • K-Ras(G12C) Inhibito...

    K-Ras(G12C) inhibitor 6 is an irreversible, allosteric inhibitor of the K-Ras(G12C) mutant that causes 100% modification of the protein when used at 10 μM for 24 hours in vitro.

  • Maleuric acid

    Maleuric acid (N-Carbamoylmaleamic acid) is anti-mitotic and can be used in biological research in conjunction with radioautography.